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Abstract
Background: Baculovirus expression vector system (BEVS) has become a standard in
recombinant protein production and virus-like particle preparation for numerous applications.
Findings: We describe here protocols which adapt baculovirus generation into 96-well format.
Conclusion: The established methodology allows simple baculovirus generation, fast virus
titering within 18 h and efficient recombinant protein production in a high-throughput format.
Furthermore, the produced baculovirus vectors are compatible with gene expression in vertebrate
cells in vitro and in vivo.
Background
Current and completed genome projects are sources of
numerous novel open reading frames, which also are
likely to provide new protein drug candidates or targets
for medical use. This sequence information requires
fluent high-throughput methods to turn into biologi-
cally relevant functional information. Over the last 20
years the safety, simplicity and capacity for the large
inserts has made BEVS as a standard in recombinant
protein production [1]. More recently, it has also become
a popular choice for gene transfer into vertebrate cells
[1-3]. Tetra-promoter vector system has previously been
c o n s t r u c t e db yo u rg r o u pi no r d e rt oa c h i e v es i m p l ea n d
parallel gene expression in mammalian, bacterial and
insect cells with a single cloning step [4]. This universal
promoter was also applied in the current study. Use of
hybrid promoters active in different cell types further
extends BEVS utilities. However, no reports of successful
96-well plate generation of baculoviruses are available,
despite of high demand for true high-throughput
screening (HTS) applications [4-6].
When expressing recombinant proteins in insect cells, or
transducing vertebrate cells, amplification and titer
determination of recombinant virions are important in
obtaining accurate and consistent results. Often the titer
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infected cells using laborious and time-consuming
plaque formation and/or end-point dilution assays [7].
Several improved protocols for virus titering have been
described but only a few of them allow rapid virus
titering. The existing fast methods rely on troublesome
protocols, reagents and facilities [8-13]. Furthermore,
unlike the conventional and accepted measure of
infective titer, these methods are based on viral particle
or genome copy number measurements. In the current
study, we describe simple 96-well protocols for the
generation and fast (18 h) titering of recombinant
baculoviruses.
Construction of the baculovirus shuttle vector
containing an EGFP expression cassette (F-bacmid)
To allow easy validation of virion production and fast
titering, we first incorporated an enhanced green
fluorescent proteins (EGFP) expression cassette under
the control of the insect polyhedrin promoter (pPolh)
into the baculovirus genome by random Mu-based
transposition: The baculovirus genome (bacmid) was
isolated from the DH10Bac cells (Invitrogen, Carlsbad,
CA, USA) and subsequently transformed into the DH10B
cells (Invitrogen). Colonies resistant for kanamycin, and
sensitive to tetracycline, [14] were selected. The helper
plasmid, providing Tn7-transposition proteins, was
isolated similarly with the exception that the selection
s c h e m ew a sr e v e r s e da sc o m p a r e dt ob a c m i ds e l e c t i o n .
The cassette expressing EGFP was prepared by using the
following procedure: pfastbac1EvoIEGFP [15] plasmid
was digested with SwaI and SnaBI. The sequence
containing EGFP gene under the polyhedrin promoter
was isolated and blunted with the T4 DNA polymerase
and ligated with the EcoRV-digested pEntranceposon
(cam
r) plasmid (Finnzymes, Espoo, Finland). The
accomplished plasmid was cut with BglII and the
fragment containing pPohl-EGFP cassette flanked by
inverted terminal repeats of Mu transposon was used in
transposition reaction according to manufacturer's
instructions (Finnzymes). The EGFP expression cassette
containing bacmids were screened for the antibiotic
resistance using chloramphenicol. The resultant recom-
binant baculovirus genome was named as F-bacmid
(Figure 1).
Determination of the EGFP expression cassette
integration site in the baculovirus genome
After introducing the EGFP expression cassette into the
baculovirus genome (F-bacmid), the random integration
site was determined by inverted PCR. The F-bacmid DNA
was isolated, cut with BsrGI, re-ligated and linearised
with FseI. Linearized DNA was amplified by PCR
using 5'-ATACTCGTCGACAAGCTTCTCG-3' and 5'-
GTATCAACAGGGACACCAGGAT-3' primers, which
amplified the DNA outwards from the EGFP expression
cassette. The amplified fragments were purified using
Wizard
® SV Gel and PCR clean up system (Promega,
Madison, WI, USA) and cloned into pGEM
®-T Easy
vectors (Promega) according to manufacturer's instruc-
tions. Clones were screened by blue-white screening and
EcoRI restriction enzyme analysis. To reveal the integra-
tion site of the EGFP expression cassette, the TA-cloned
inserts were sequenced with primers 5'-AATACGACT-
CACTATAGGG-3' and 5'-CATACGATTTAGGTGACACTA-
TAG-3'. The obtained nucleotide sequences were fed into
the NCBI-BLAST
® (National Centre of Biotechnology,
USA- Basic Local Alignment Search Tool) search pro-
gram. Sequence analysis revealed that the integration site
was in the ODV-E66 gene. The ODV-E66 is a structural
protein found on the envelope of occlusion derived
baculovirus, but not on the budded baculovirus [16].
Thus, the integration does not disturb viral replication,
but enhances safety by eliminating the formation of
intact occlusion derived viruses.
Construction of a F-bacmid containing DH10BacΔTn7
E. coli strain
To construct an E. coli strain that allows Tn7-mediated
generation of recombinant baculoviral genomes without
background [17], F-bacmid containing DH10B cells were
transformed with a helper plasmid {pMON7124 [14]}.
A bacterial clone was further transformed by the
pBVboostΔamp plasmid [17] and selected as described
earlier for the deletion of the cryptic E.coli attTn7 site
[17]. The strain was named as a DH10BacΔTn7EGFP.
Generation and functionality of recombinant
baculoviruses
Recombinant bacmids were prepared as described
previously [4] using E. coli strain DH10BacΔTn7EGFP.
Cells were transformed with pBVboostFG [4] donor
Figure 1
Construction of the modified baculovirus shuttle
vector, F-bacmid. Transposition reaction was used to
transfer the EGFP cassette into isolated baculovirus genome
(bacmid). The MuA transposase provided the proteins
needed for the integration reaction. The resultant F-bacmid
was analysed for the EGFP cassette integration site. The site
was found to be in the ODV-E66 gene.
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form of vascular endothelial growth factor D (VEGF-
DΔNΔC) [19]. These proteins represent medically and
biotechnologically relevant examples of which we have
years of experience. Control vectors were generated by
conventional bacmids [17] and recombinant baculo-
viruses were produced by transfecting Sf9 (Spodoptera
frugiperda, Invitrogen) insect cells as described previously
[4]. Virus production in Sf9 cells was detected by
fluorescence microscopy (F-bacmid viruses). Titers were
determined by using end-point dilution method [7].
Protein production was performed by infecting Sf9 cells
in Insect X-press medium (BioWhittaker, Heidelberg,
Germany) or transducing mammalian cells with pro-
duced viruses. Same viruses could be used for both cell
types due to the built in universal promoter system
directing transgene expression simultaneously under
p10, polyhedron, T7 and chicken B-actin tetra-promoter
[4]. Sf9 infection (MOI 5) was accomplished with the
secondary virus preparation and allowed to continue for
4 days at 27°C, shaking at 110 rpm. Mammalian cells
[Human hepatoma (HepG2), rat glioma (BT4C), and
human ovarian cancer (SKOV-3)] cells were cultured in
Dulbecco's Modified Eagle's Medium (DMEM, Sigma)
and transduced with the unpurified secondary virus
preparations (MOI 270). Fresh medium was changed
after 24 hours transduction and cells were incubated for
another 24 hours prior sample analysis. Both the
transduced cells and medium were analyzed by immu-
noblotting using 1:2000 dilution of polyclonal rabbit
anti-avidin [20] and 1:1000 mouse anti-hVEGF-D (R&D
systems, Minneapolis, MN, USA) antibodies. The con-
centration of VEGF-D
ΔNΔC was also analyzed by ELISA
(Quantikine
® Human VEGF-D kit). Production of avidin
and VEGF-D
ΔNΔC by the F-bacmid viruses was compar-
able to the viruses produced by the original bacmid
[14,17] (Figure 2). Altogether, no differences in the level
of protein expression were detected in mammalian or
insect cells between the bacmids. These results also
indicate that the EGFP expression cassette integration
into the ODV-E66 gene did not affect titer or protein
production of F-bacmid derived viruses.
Titer determination by flow cytometry
To establish a simple and fast 96-well protocol for
titering of recombinant baculoviruses, the F-bacmid
based EGFP expressing baculoviruses were serially
diluted in duplicates into Insect X-press medium and
0 . 5m lo fe a c hd i l u t i o nw a su s e dt oi n f e c t0 . 5m lo fS f 9
cells (2 × 10
6 cells/ml). The infection was carried out in
suspension culture that mimics well, typical large-scale
Figure 2
Comparison of protein production rate of the
F - b a c m i da n do r i g i n a lb a c m i di ni n s e c ta n d
mammalian cells. Medium was harvested from insect and
mammalian cells at 96 and 48 hours after virus addition,
respectively. Equal amount of total protein was loaded into
immunoblots. (A) The VEGF-D
ΔNΔC production in insect
cells analyzed by ELISA. (B) Immunoblot of VEGF-D
ΔNΔC
production in insect cells. Lanes 1–4 represent medium
samples of FG-VEGF-D
ΔNΔC produced by conventional
bacmid system and the three F-bacmid produced VEGF-
D
ΔNΔC.L a n e s5 –8 show cell lysates from the same samples.
Lane 9 is the positive control for VEGF-D. (C) Lanes 1–4a r e
the medium samples from two avidin controls produced by
conventional bacmid system (lanes 1 and 2) compared to two
F-bacmid produced avidins (lanes 3–4). Lanes 5–8a r ec e l l
lysates from the same samples. Lane 9 is positive control for
avidin. (D) ELISA results for theVEGF-D
ΔNΔC production in
mammalian cells. (E) An immunoblot analysis of avidin
production in mammalian cells. Lanes 1 and 2 represent
HepG2 medium samples of avidin control and F-bacmid
avidin, respectively. Lanes 3–4 show the medium samples
from BT4C cells, and lanes 5 and 6 from avidin produced in
SKOV 3 cells. Lane 7 is the positive control for avidin. (M)
Marker (SeeBlue
® PreStained Standard, Invitrogen).
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was allowed to continue for 18 or 24 hours at 27°C with
shaking at 270 rpm. The samples were centrifuged for
5m i n u t e sa t5 0 0×g ,r e s u s p e n d e di n2 %F B Si nP B S ,a n d
analyzed by flow cytometry (FACSCantoII, Becton
Dickinson, Franklin Lakes, NY, USA) to reveal the
percentage of the infected cells. Results were normalized
according to Mulvania et al. [11] and virus titers were
calculated (1) as an average from all dilutions which
contained 1 to 10% of EGFP positive cells [21] after
normalization:
Titer ifu ml
averaged EGFP   of duplicate samples
imum 
(/)
%
max
=
E EGFP 
dilution factor  cells per ml
%
××
(1)
It was observed that 24 h incubation resulted in 4 times
overestimation of the viral titer (Figure 3). This is
probably due to the secondary infections due to virus
production in insect cells [11]. Thus, infection time was
restricted to 18 h to eliminate this possibility.
We assessed the accuracy of titers obtained with the flow
cytometry by comparison to those values obtained using
the end-point dilution method [7]. The titers obtained
from both methods were comparable (Table 1). The end-
point dilution method yielded on average 1.8 times
higher titers than flow cytometric analysis. A linear
regression analysis revealed an excellent correlation
coefficient of 0.9924 between titers obtained using
both methods (Figure 3). In addition, differences in
variances were not statistically significant, further indi-
cating reliable and constant results. As compared to the
previously published titering protocols, the described
FACS protocol avoids the inconvenience and expensive
reagents involved in the immunostaining-based proto-
cols [10,11,22]. To get reproducible results, only cells in
exponential phase of growth and low enough passage
number (below 40) was used. Good aeration was
provided via shaking and by using square wells.
Baculovirus generation in a 96-well plate format
Next, we tested the suitability of baculovirus production
in the 96-well format. Even though there is a clear need
for true high-throughput screening (HTS) methods, no
reports of a successful 96-well adaptation of baculovirus
generation are available [5]. Baculovirus generation was
carried out by transfecting Sf9 cells in suspension using
deep 96-well plates (96-well culture block, Millipore,
Billericia, MA, USA) in which the shape of the well was
square and the bottom was round. The transfection
solution consisted of 40 μl of Insect X-press medium,
0.6 μl of cationic lipid reagent Cellfectin
® (Invitrogen)
and 5 μl of F-bacmid DNA. The bacmid DNA was
isolated with Montage BAC96 Miniprep Kit according to
the manufacturer's instructions (Millipore). Following
incubation of the transfection solution at room tem-
p e r a t u r ef o r3 0m i n u t e s ,0 . 5×1 0
6 Sf9 insect cells in
0.5 ml of medium (Insect X-press, BioWhittaker,
Heidelberg, Germany) were added. After 5 hours of
incubation at 27°C with shaking at 270 rpm (Innova44
shaker, New Brunswick Scientific Edison, NJ, USA), an
additional 0.5 ml of Insect X-press medium was added to
the cells and the samples were further incubated.
Fluorescence microscopy and flow cytometry were used
to detect virus production. We could reliably detect
progression of virus infection in insect cells (baculovirus
generation) as well as protein production. 88–100% of
the 96 wells contained viruses after transfection in
optimal conditions (Figure 4). The percentage of the
F-bacmid (EGFP) transfected Sf9 cells increased on a
daily basis between days 3 to 7 (Figure 4). At day 7, the
percentage of positive cells per well was between 70 to
85% (Figure 4). Most of the previous multi-well studies
show successful virus production only in the 24-well
plates [5,6]. The success of virus generation in the96-well
plates was obtained by extensive optimization of the
infection conditions. The use of square shaped wells,
Figure 3
Titer determination by flow cytometer.( A )T i t e r so f
two virus samples (A and B) analyzed three times by the 18 h
fluorescent based flow cytometric assay and end-point
dilution method. (B) Consistency of the titers determined by
flow cytometer after 18 hours of incubation. (C) Titer
determined with flow cytometer 24 hours post infection led
to overestimation of virus titer. In average titer determined
24 hours post infection were 4 times higher than the ones
determined 18 hours post infection. This might be due to
viral spread and secondary infections. (D) Comparison of the
end-point titer and the titer determined by flow cytometer.
Correlation coefficient (R = 0.9924) indicated good
correlation between the two titration methods.
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aeration) and suspension culturing were found to be
crucial for the successful virus production.
The primary virus stocks could be used for the virus
amplification and for immediate protein production,
indicating high primary virus titers. Two microliters of
p r i m a r yv i r u sw a su s e dt oi n f e c t1×1 0
6Sf9 cells in one
ml. The cells were incubated at 27°C, shaking at
270 rpm for 7 days. Successful protein production was
detected by immunoblotting (Figure 4).
In conclusion, we present protocols which allow
baculovirus generation and fast titering in a 96-well
format. All virus generation steps are amenable for
automation. The presented protocols are thus highly
useful for widely used BEVS, as well as a basis for HTS
applications and gene transfer into vertebrate cells.
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